October 25, 2011

Mayo Clinic Detective Work Shows Possible Side Effect in Macular Degeneration Drug


Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando. Sophie Bakri, M.D., had been treating patients in her clinic with Food and Drug Administration-approved ranibizumab (Lucentis), when she began noticing a change in some patients.

dLife, 10/25/11

Additional coverage: e! Science News, MarketWatch, MediLexicon, Medical Xpress, BioPortfolio

Tags: Ophthalmology

Please sign in or register to post a reply.
Contact Us · Privacy Policy